Coming soon: Drugs for weight loss have been used for a long time in practice, however recent developments prompted the need for this special edition. The goals of this collection are to discuss ...

Glucagon-like peptide-1 receptor agonists (GLP-1), while originally developed to treat diabetes, have demonstrated efficacy in preventing cardiovascular events in overweight or obese (BMI>27) patients ...

Taking to Instagram over the weekend, the "Truth Hurts" singer not only revealed that she achieved her "weight release" goal — she also lost more than 10 BMI points and 16 percent body fat since ...

Researchers at CNIO have discovered that blocking the mitochondrial protein MCJ in brown fat increases heat production and leads to weight loss in obese mice, offering protection against ...

Initial clinical characteristics assessed in the patients included age, sex, weight, body mass index (BMI), serum albumin, hemoglobin, neutrophil-to-lymphocyte ratio, presence of comorbidities ...

Europe's largest pharmaceutical firm, Novo Nordisk, revealed positive trial results for its next-generation obesity drug, amycretin, marking a major step in its competition within the increasingly ...

Dr. Rajan explained, "If you think obesity is just about willpower, you don't fully understand this complex metabolic condition." He went on to clarify, "What Oprah is referring to here is called ...

The revised classification system introduces two stages in obesity — ‘innocuous obesity’, characterised by increased body fat without organ or metabolic dysfunction; the second stage is ...

In addition to the Canadian Community Health Survey (CCHS; see Box 1), the following key surveys are discussed in this chapter: First Nations Regional Longitudinal Health Survey 28 29 The First ...

CNN: What are advantages and disadvantages of this type of classification? In what ways could it change clinical care? Wen: I think it’s good to be more precise about defining obesity.